We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGEN
2376
Agenus
AGEN
$300M
$100K ﹤0.01%
21,871
+15,893
+266% +$55K
DYN icon
2377
Dyne Therapeutics
DYN
$4.95B
$99.9K ﹤0.01%
10,495
+7,697
+275% +$84.7K
MMYT icon
2378
MakeMyTrip
MMYT
$5.78B
$99.9K ﹤0.01%
1,019
-1,724
-63% -$174K
FLUT icon
2379
Flutter Entertainment
FLUT
$17.3B
$99.7K ﹤0.01%
349
-656
-65% -$161K
VTLE
2380
DELISTED
Vital Energy
VTLE
$99.5K ﹤0.01%
6,185
-958
-13% -$15.7K
STAA icon
2381
STAAR Surgical
STAA
$1.25B
$99.3K ﹤0.01%
5,919
+4,673
+375% +$82.4K
EXAS
2382
DELISTED
Exact Sciences
EXAS
$99.2K ﹤0.01%
1,866
-7,395
-80% -$376K
CIM
2383
Chimera Investment
CIM
$1B
$99K ﹤0.01%
7,140
+3,423
+92% +$43.7K
QURE icon
2384
uniQure
QURE
$3.13B
$98.8K ﹤0.01%
7,085
+5,538
+358% +$74.5K
DGICA icon
2385
Donegal Group Class A
DGICA
$694M
$98.7K ﹤0.01%
4,928
+4,022
+444% +$78K
VERA icon
2386
Vera Therapeutics
VERA
$2.16B
$98.6K ﹤0.01%
4,186
+2,757
+193% +$62K
RDUS
2387
DELISTED
Radius Recycling
RDUS
$98.6K ﹤0.01%
3,321
+2,603
+363% +$76.4K
WEN icon
2388
Wendy's
WEN
$1.43B
$98.5K ﹤0.01%
8,629
+2,994
+53% +$36.5K
VERV
2389
DELISTED
Verve Therapeutics
VERV
$98.5K ﹤0.01%
8,773
+4,884
+126% +$27.8K
EPC icon
2390
Edgewell Personal Care
EPC
$1.31B
$98.3K ﹤0.01%
4,201
+1,692
+67% +$46.9K
IMVT icon
2391
Immunovant
IMVT
$8.36B
$98.2K ﹤0.01%
6,140
+4,273
+229% +$64.6K
EBTC
2392
DELISTED
Enterprise Bancorp
EBTC
$98.2K ﹤0.01%
2,477
+1,978
+396% +$75.5K
FSBC icon
2393
Five Star Bancorp
FSBC
$1.15B
$98K ﹤0.01%
3,435
+1,359
+65% +$37.3K
NPKI
2394
NPK International
NPKI
$1.17B
$98K ﹤0.01%
11,518
+7,680
+200% +$56.3K
ARDX icon
2395
Ardelyx
ARDX
$982M
$98K ﹤0.01%
24,989
+13,736
+122% +$56.7K
SMA
2396
SmartStop Self Storage REIT
SMA
$1.89B
$97.9K ﹤0.01%
+2,701
New +$95.2K
UNIT
2397
Uniti Group
UNIT
$2.27B
$97.8K ﹤0.01%
22,634
+19,414
+603% +$87.2K
IART icon
2398
Integra LifeSciences
IART
$1.35B
$97.6K ﹤0.01%
7,958
+6,814
+596% +$98.9K
DMC
2399
Del Monte Corp
DMC
$1.44B
$97.6K ﹤0.01%
3,010
+775
+35% +$25.5K
PKX icon
2400
POSCO
PKX
$17.3B
$97.6K ﹤0.01%
+2,012
New +$92.6K

Similar funds

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.